## ## ## ## |||Page| |---|---|---| |Trustees'
report||1-3| |Independent
examiner's
report||| |Statement offinancial activities||5-6| |Summary
income and expenditure|account|| |Balance sheet||| |Notes to the financial statements||9-18| ## ## ## ## ## ## ## ## ## ## ## ## ## |Dr Gareth Payne|||| |---|---|---|---| |Dr Jeremy Bland|||| |Dr James Burge|(Resigned|13November|2020)| |Dr Shereef Mytheen|(Resigned|13November|2020)| |Dr Ming Lai|||| |DrAdrian
Fowle|(Resigned|13November|2020)| |Dr Ronit Pressler|||| |Dr Veronica Leach|||| |DrArup
Mallik|(Resigned|13November|2020)| |Dr Rachel Thornton|(Resigned|13November|2020)| |Professor
M Koltzenburg|||| |Ms Lesley Chandra|||| |DrAndrew
Michell|||| |Dr Mark Baker|||| |Dr Daniel Konn|||| |Dr Sushma
Goyal|||| |Dr Stephan Jaiser|(Appointed|13November|2020)| |Dr Nandini
Mullatti|(Appointed|13November|2020)| |Dr Elisaveta Sokolov|(Appointed|13November|2020)| |Dr Jacquie Deeb|(Appointed|13November|2020)| ## ## ## ## ||||N
0||O
O|W||CIL
Ol
O|IA|CD
CD|IA
IA|||CI||| |---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---| |||||||||CD|IA||40|||||| ||||C||O
CLI|W||||||||||| ||||E||CI
CLI|||||||||||| ||||00C|||||||||||||| ||||IU|||||||||||||| ||||0
0
0|N
13C|O
CC
CI
CC|W||||CD|||Cl
Cl
Cl
IA|||| ||||Ib|||||||||||||| ||||ID|||||||||||||| ||||Cl
0|ID
'0
C|O
CLIO
CLI|Cll||CDO
Ol|IA
IA|LA
CC|||CD
CO
CO
Cl|||OE| ||||Cl|||||||||||||| ||||Cl|||||||||||||| ||||IC0||CLI
CI|W||Ol|O
'll|||||||| ||||||CLI|||4C|CC|CD||||||| ||||00|N
U|~
CCO|Ill||||||||IO||CC
CII
CO| ||||E|4|CC|||||||||||| |Q0
0
0)|||0
'U
C
lU
'U
4l0
N4l|N
'0
L
4|t-
O
III|W||O
IA
IO|'|CD
CO
CD|||CI
CI
IA|||| |Z||||||||||||||||| |IL0
ILD|||'U
Cl0
Cl|N
'0
C|~
Ol
O
Ol|W||Ol|O
0|IO
CLI|CO
CI
CO||Ol
IA
CI|||CC
Ill
CI
OO| ||||Cl|||||||||||||| |LLIX|||CD|||||||||||||| |||||||N||||||||||| |O||||||CI0Z||||||||CI||| |X|tlat|||||||||||||||| ||LU|||||||||||||||| |0||0||||||||||||||| |0|I
0|LU
5|||||||||||||ID
I0
4
ID|| |I-
LLI
O0
loz
M
E
IL
tQ
LLIzI-|0z
LL
IL
I
z
K
LU
LU
I-
N|0
g
LLI
I
0
U.|||||0
CI
E00C|'U
N
Vl
0
ICC0
CI|ID
ID
0
IC
0
m
'C
IC|N
C
Cl
E
N
Cl
'C|0
E00C
IC0|C0
CI
'0
4I
CC
IU|Vl
N
0
IC
Cl
J2
IC
IC0|N
C0E
N
CI
C0
N
CI
ID
N0
NC
ClUl
YlZ|N
ID
I0
0
Cl0
Ul00
Ul
0
Ul
C
0
Cl
Z|4l
ClC
N
+~| |||O|Ol||||||||| |---|---|---|---|---|---|---|---|---|---|---|---| |||CI|||||||||| |E||O
CI|CII|||||CI
CI
CI
Cl|ooo
Cl||| |0
'O|||||||||||| |C|||||||||||| |UJ|||||||||||| |'O
0|ID
'0L|O
CI!
Cl|Cll|||||CO
Cl
Cl|IO
CI
CI||| |||CI!||||||CII|Ctt||| |tD0|||||||||||| |'0
ID
0|tD
'O
C|O
CI|IIC||oE||||Ctt
CO||| ||||||||||ttt||| |N|||||||||||| |ID|||||||||||| |Dl||c-
OCo|CII||CO||CO
ttt||Cl
Cl||| |||OC|||CO||CO||||| ||||||Ctt||Ctt||Ol||| |N
E|N
'O
L|c
CV
O
CV|Itl||Ctt
Ctt
IO|IO||CI
CI
CI|ooo||| |0OL|||||||||||| |IU|||||||||||| |'0
Dl0|N
'0c|c-
o
CC|CIC|||||CO
CI
CI||ID
4l|| |I||||||||||4l|| |N|||||||||||| |Dl|||||||||||| |I4"|||||||||||| |||||||||||O|| |'0
N0|N
'0
c|c
0!
o0!|Itl||CI!
Ill
CI
CD|CV
CI!
IO|IO|||ID
N
Ol00|| |Dl||||||||||ID|| |N|||||||||||| |LD||||||||||ID
ID
N|| ||||N
Dl
0Z|||||||ID0
C
ID
IDC|tDS
04!| |||||||||||ID
Ol|Ol
C| |||||ID
I0
ID||||||4!
Ih0
O|C
C
00| |||||N||||||0C|E0| |||||ID
I0||||||ID
ID|4
4l| |||||0
Dl0
Ol
C0
Ol
0
Ol
C
O
4l
Z|4l
NC
N
JD|ID
13
4
ID
fl
ID
ID
4
ID
ID
N
ID0
G|N
'O
C
C
4l
4l
0
E
4lZ|CI
Ctt
CI
Ctt
ID
N
N0
ID
ID
J2
'O
C
IL|Ol
CI
Ol
4lC
l
CI
ID
N4l0C
ID
ID
'O
C
IL|0
ID
4!0C
IDC
IC
40
Cl
E
4l
N
4l
I-|ID
4l
IDO.
IC0
ID0
E
8C| ## ## ## ||||All income funds|| |---|---|---|---|---| ||||2021
F|2020f| |Gross income|||39,819|28,552| |Gains/(losses)
on|investments||6,037|(7,579)| |Transfer from/(to)|endowment|funds|3,622|(4,438)| |Total income
in the reporting||period|49,478|16,535| |Total expenditure|from income funds||21,091|25,869| |Net income/(expenditure)
for the year|||28,387|(9,334)| ## ## |||||2021||2020|| |---|---|---|---|---|---|---|---| ||||Notes|6||6|| |Fixed assets|||||||| |Investments|||||91,858||82,199| |Current assets|||||||| |Debtors|||12|60,284||60,783|| |Cash at bank and|in|hand||53,516||32,209|| |||||113,800||92,992|| |Creditors: amounts||falling due within|||||| |one year|||13|(11,638)||(9,558)|| |Net current assets|||||102,162||83,434| |Total assets less|current liabilities||||194,020||165,633| |Capital funds|||||||| |Endowment
funds|-|Dr Last Memorial|||||| |Fund|||||10,000||10,000| |Income funds|||||||| |MSC Fund||||12,006||12,006|| |Dr Last Memorial|Fund|||963|||| |Christine
and Adrian||Fowle Prize Fund||5,750|||| ||||15||18,719||12,006| |Unrestricted
funds|||||165,301||143,627| ||||||194,020||165,633| ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## |||Unrestricted|Restricted|Total|Total| |---|---|---|---|---|---| |||funds|funds||| |||2021|2021|2021|2020| |||6|F|6|F| |Donations|and gifts||||4,239| |Membership|fees|17,941||17,941|14,853| |Other|||6,250|6,250|| |||17,941|6,250|24,191|19,092| |Forthe year ended 30June 2020||19,092|||19,092| ## ## ## ## |||||2021|2020| |---|---|---|---|---|---| |||||6|| |Delegate|fee||income|5,001|3,940| |Exhibitor|fee||income|7,400|1,601| |||||12,401|5,541| |A~li|1|t|d||| |Unrestricted|||funds|12,401|| |Forthe|year||ended 30June 2020||| |Unrestricted|||funds||5,541| ||||||5,541| ||Unrestricted|Restricted|Total|Total| |---|---|---|---|---| ||funds|funds|2021|2020| |Income From Listed Investments|2,207|963|3,170|3,771| |Bank Interest|57||57|148| ||2,264||3,227|3,919| |Forthe year ended 30June 2020|2,725|1,194||3,919| ## ## ## |5|Charitable
activities|Charitable
activities||||||| |---|---|---|---|---|---|---|---|---| |||||Scientific|Triennial|Grants|Total|Total| |||||Meetings|||2021|2020| |||||6|||6|E| ||Meeting costs|||||||7,208| ||ACNS meeting|costs||||||3,114| ||Other meeting|costs||(127)|||(127)|182| |||||(127)|||(127)|10,504| ||Grant funding|ofactivities (see note 6)||||||| |||||||1,612|1,612|9,425| ||Share ofsupport costs (see note 7)|||9,995||6,263|16,258|2,559| ||Share ofgovernance||costs (see note|||||| ||7)|||3,348|||3,348|3,381| |||||13,216||7,875|21,091|25,869| ||A~li
1
r|d||||||| ||Unrestricted
funds|||13,216||7,375|20,591|| ||Restricted funds|||||500|500|| |||||13,216||7,875|21,091|| ||Forthe year ended||30June 2020|||||| ||Meeting costs|||5,228|1,980|||7,208| ||ATCN costs|||||||| ||ACNS meeting|costs||3,114||||3,114| ||Other meeting|costs||182||||182| |||||8,524|1,980|||10,504| ||Grant funding|ofactivities (see note 6)||||||| |||||||9,425||9,425| ||Share ofsupport costs (see note 7)|||2,559||||2,559| ||Share ofgovernance||costs (see note|||||| ||7)|||3,381||||3,381| |||||14,464|1,980|9,425||25,869| ||A~li
b
t|d||||||| ||Unrestricted
funds|||14,464|1,980|4,425||20,869| ||Restricted funds|||||5,000||5,000| |||||14,464|1,980|9,425||25,869| ## ## ## ||||2021|2020| |---|---|---|---|---| ||||6|| |Grants|to|organisations||500| |Grants|to|individuals|1,612|8,925| ||||1,612|9,425| ## ## |Support cos|ts||||| |---|---|---|---|---|---| |||Support Governance||2021|2020| |||costs|costs||| |||E|6||| |Website||1,863||1,863|990| |Clerical Assistance||12,527||12,527|| |Subscription|- IFCN|498||498|964| |Subscription|- JNC|250||250|250| |Subscription|-AANEM|976||976|| |Bank charges||201||201|355| |Sundry expenses||(57)||(57)|| |Examination|fees||2,653|2,653|2,656| |Accountancy|||240|240|240| |Legal and professional|||455|455|485| |||16,258|3,348|19,606|5,940| |Analysed
between|||||| |Charitable
activities||16,258|3,348|19,606|5,940| ## ## ## ## ## ||||||||2021|2020| |---|---|---|---|---|---|---|---|---| ||||||||Number|Number| |Total||||||||| |Net gains/(losses)||on investments||||||| ||||Unrestricted|Endowment|Total|Unrestricted|Endowment|Total| ||||funds|funds||funds|funds|| |||||general|||general|| |||||2021f||2020
f|2020
f|2020
F| |Revaluation
of||||||||| |investments|||6,037|3,622|9,659|(7,579)|(4,438)|(12,017)| |Fixed asset investments||||||||| |||||||Listed|Unlisted|Total| ||||||investments
investments|||| |||||||f|f|| |Cost or|valuation|||||||| |At 1 July|2020 &30|June|2021|||72,199|10,000|82,199| |Carrying|amount|||||||| |At 30June 2021||||||72,199|10,000|82,199| |At 30June 2020||||||72,199|10,000|82,199| ## ## ## ## ## |13|Creditors: amounts|falling|due within one year|||| |---|---|---|---|---|---|---| ||||||2021|2020| |||||Notes|6|8| ||Deferred income|||14|8,512|6,932| ||Accruals||||3,126|2,626| ||||||11,638|9,558| |14|Deferred income|||||| ||||||2021f|2020
8| ||Deferred scientific meeting||delegate fees||8,512|6,932| ## ## |16|Analysis of|net assets between funds||||| |---|---|---|---|---|---|---| ||||Unrestricted|Restricted|Endowment|Total| ||||Fund|Funds|Fund|| ||||6|F||6| ||Fund balances at 30June 2021 are|||||| ||represented|by:||||| ||Investments||81,858||10,000|91,858| ||Current assets/(liabilities)||83,443|18,719||102,162| ||||165,301|18,719|10,000|194,020| ||Fund balances at 30June 2020 were|||||| ||represented|by:||||| ||Investments||72,199||10,000|82,199| ||Current assets/(liabilities)||71,428|12,006||83,434| ||||143,627|12,006|10,000|165,633| ##